|
|
Article: Zosano Pharma, Inc. to Provide Pipeline Updates at the 2009 AAPS Annual Meeting.
- Article from:
- Computer Technology Journal
- Article date:
- November 19, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced that the company will present two posters at the 2009 Annual Meeting of the American Association of Pharmaceutical Sciences (AAPS) on November 10 in Los Angeles, Calif. at the Los Angeles Convention Center.
One poster titled "Demonstrating 2-year Ambient Storage Shelf Life for Parathyroid Hormone PTH (1-34) Coated on a Novel Transdermal Microprojection Delivery System" highlights the formulation and packaging of the company's novel PTH-coated transdermal microprojection system that was tested in the recent Phase 2 clinical ...
Related newspaper, magazine, and journal articles:
|
|
Article: Zosano Pharma, Inc. Announces Positive Results of ...
Business Wire;
October 27, 2008 ;
700+ words
... ... Density FREMONT, Calif. -- Zosano Pharma, Inc., a privately held ... company developing a novel transdermal delivery technology, today announced ... attributable to its unique transdermal delivery profile. The hip is one ...
|
|